Literature DB >> 1668058

[Inhibitors for protein tyrosine kinases, erbstatin, genistein and herbimycin A, induce differentiation of human neural tumor cell lines].

M Matsumoto1.   

Abstract

Recent reports suggest that protein phosphorylation is involved in neural differentiation. We have found that specific inhibitors of protein phosphorylation at tyrosine residues, Erbstatin, Genistein, Herbimycin A, effectively induce neural differentiation in a human neuroblastoma cell line SK-N-DZ and a human medulloblastoma cell line Med-3, as indicated by the marked increase in the number of neurites/cell and in the expression of neurofilaments (160 k) detected by immunohistochemical studies. Possible involvement of protein phosphorylation at tyrosine residues in the differentiation of neural tumor cells was stressed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668058

Source DB:  PubMed          Journal:  Nihon Geka Hokan        ISSN: 0003-9152


  4 in total

1.  CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells.

Authors:  Yuan-Shan Fu; Qian Wang; Jing-Xin Ma; Xiang-Hong Yang; Mo-Li Wu; Kai-Li Zhang; Qing-You Kong; Xiao-Yan Chen; Yuan Sun; Nan-Nan Chen; Xiao-Hong Shu; Hong Li; Jia Liu
Journal:  Mol Oncol       Date:  2011-11-25       Impact factor: 6.603

2.  Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity.

Authors:  Song Zhang; Huan Liu; Hong Li; MoLi Wu; Yang Yu; FengZhi Li; XiaoXin Cheng
Journal:  RSC Adv       Date:  2018-04-16       Impact factor: 4.036

3.  Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.

Authors:  Sami Khoshyomn; David Nathan; Gregory C Manske; Turner M Osler; Paul L Penar
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

4.  Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification.

Authors:  Subhasree Roy Choudhury; Surajit Karmakar; Naren L Banik; Swapan K Ray
Journal:  Invest New Drugs       Date:  2009-09-24       Impact factor: 3.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.